Does dNA-methylation analysis identify the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies?
Methylation of certain genes can be detected frequently in patients with monoclonal gammopathies. The current data suggest that methylation of ECAD is a marker of disease progression in patients with MM and PCL.
The data suggest that NL exhibited hepatoprotective effects in CCl4-intoxicated rats via antioxidative mechanism.